How big is the Digital Biomarkers Market?

The Digital Biomarkers Market size is expected to reach USD 3.64 billion in 2024 and grow at a CAGR of 19.90% to reach USD 9.02 billion by 2029. Read More

What is the current Digital Biomarkers Market size?

In 2024, the Digital Biomarkers Market size is expected to reach USD 3.64 billion. Read More

Who are the key players in Digital Biomarkers Market?

ActiGraph, Fitbit Health Solutions, Biogen, F. Hoffmann-La Roche Ltd. and Huma are the major companies operating in the Digital Biomarkers Market. Read More

Which is the fastest growing region in Digital Biomarkers Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Digital Biomarkers Market?

In 2024, the North America accounts for the largest market share in Digital Biomarkers Market. Read More

What years does this Digital Biomarkers Market cover, and what was the market size in 2023?

In 2023, the Digital Biomarkers Market size was estimated at USD 2.92 billion. The report covers the Digital Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Digital Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Digital Biomarkers Market Share

Statistics for the 2023 & 2024 Digital Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Digital Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Digital Biomarkers Industry

The digital biomarkers market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Major market players include Akili Inc., ActiGraph LLC, AliveCor Inc., Fitbit Health Solutions, Empatica Inc., Biogen, F. Hoffmann-La Roche Ltd, Koneksa, IXICO PLC, and Huma.